References: Tobin DJ. Biochemistry of human skin - our brain on the outside. Chem Soc Rev. 2006;35(1):52-67.
Bos JD. Skin Immune System: Cutaneous Immunology and Clinical Immunodermatology. 3rd ed. Boca Raton, FL: CRC Press; 2005:3-12.
Luu-The V, Duche D, Ferraris C, Meunier J-R, Leclaire J, Labrie F. Expression profiles of phase 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin™ and full thickness model from Episkin™. J Steroid Biochem Mol Biol. 2009;116(3-5):178-186.
Karlberg A-T, Bergström MA, Börje A, Luthman K, Nilsson JLG. Allergic contact dermatitis-formation, structural requirements and reactivity of skin sensitizers. Chem Res Toxicol. 2008;21(1):53-69.
Peiser M, Tralau T, Heidler J, et al. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 2012;69(5):763-781.
Thyssen JP, Linneberg A, Menné T, Johansen JD. The epidemiology of contact allergy in the general population-prevalence and main findings. Contact Dermatitis. 2007;57(5):287-299.
European Commission. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off J Eur Union. 2006; L396/1 of 30.12.2006.
European Commission. Regulation (EC) No 1223/2009 of the European Parliament and the Council of 30 November 2009 on cosmetic products. Off J Eur Union. 2009;L342:59-209.
OECD. The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins. Part 1: scientific evidence. OECD Environment, Health and Safety Publications Series on Testing and Assessment. 2012; 168: 1-59.
OECD. The adverse outcome pathway for skin sensitization initiated by covalent binding to proteins. Part 2: use of the AOP to develop chemical categories and integrated assessment and testing approaches. OECD Environment, Health and Safety Publications Series on Testing and Assessment. 2012; 169: 1-46.
OCDE. Test No. 442C: In Chemico Skin Sensitisation: Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins. OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris. 2019. https://doi.org/10.1787/9789264229709-en.
OCDE. Test No. 442D: in vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method, OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris. 2018. https://doi.org/10.1787/9789264229822-en.
OCDE. Test No. 442E: in vitro Skin Sensitisation : In Vitro Skin Sensitisation assays addressing the Key Event on activation of dendritic cells on the Adverse Outcome Pathway for Skin Sensitisation, OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris. 2018. https://doi.org/10.1787/9789264264359-en.
Rosdy M, Clauss LC. Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air-liquid interface. J Invest Dermatol. 1990;95(4):409-414.
Ponec M. Reconstructed human epidermis in vitro: an alternative to animal testing. ATLA. 1995;23:97-110.
Netzlaff F, Lehr C-M, Wertz PW, Schaefer UF. The human epidermis models EpiSkin®, SkinEthic® and EpiDerm®: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm. 2005;60:167-178.
Götz C, Pfeiffer R, Tigges J, et al. Xenobiotic metabolism capacities of human skin in comparison with 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol. 2012;21(5):358-363.
Eilstein J, Léreaux G, Budimir N, Hussler G, Wilkinson S, Duché D. Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic. Arch Toxicol. 2014;88(9):1681-1694.
Cottrez F, Boitel E, Auriault C, Groux H. Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay. Toxicol In Vitro. 2015;29(4):787-802.
Cottrez F, Boitel E, Ourlin J-C, et al. SENS-IS, a 3D reconstructed epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study. Toxicol In Vitro. 2016;32(4):248-260.
Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-171.
Beckonert O, Coen M, Keun HC, et al. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc. 2010;5(6):1019-1032.
Lowe IJ. Free induction decays of rotating solids. Phys Rev Lett. 1959;2:285-287.
Andrew ER, Bradbury A, Eades RG. Removal of dipolar broadening of nuclear magnetic resonance spectra of solids by specimen rotation. Nature. 1959;183:1802-1803.
Lippens G, Bourdonneau M, Dhalluin C, et al. Study of compounds attached to solid supports using high resolution magic angle spinning NMR. Curr Org Chem. 1999;3:147-169.
Cheng LL, Lean CL, Bogdanova A, et al. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn Reson Med. 1996;36(5):653-658.
Cheng LL, Ma MJ, Becerra L, et al. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A. 1997;94(12):6408-6413.
Bathen TF, Sitter B, Sjøbakk TE, Tessem MB, Gribbestad IS. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation. Cancer Res. 2010;70(17):6692-6696.
Piotto M, Moussallieh F-M, Imperiale A, et al. Reproducible sample preparation and spectrum acquisition techniques for metabolic profiling of human tissues by 1H HRMAS NMR. In: Lutz P, ed. Methodologies in Metabolomics: Experimental Strategies and Techniques for Metabolomics Research. Cambridge: Cambridge University Press; 2010, 2010.
Benahmed MA, Santelmo N, Elbayed K, et al. The assessment of the quality of the graft in an animal model for lung transplantation using the metabolomics (1)H high-resolution magic angle spinning NMR spectroscopy. Magn Reson Med. 2012;68:2026-2038.
Faitot F, Besch C, Battini S, et al. Impact of real-time metabolomics in liver transplantation: graft evaluation and donor-recipient matching. J Hepatol. 2018;68(4):699-706.
Piotto M, Moussallieh F-M, Neuville A, Bellocq J-P, Elbayed K, Namer IJ. Towards real-time metabolic profiling of a biopsy specimen during a surgical operation by 1H high resolution magic angle spinning nuclear magnetic resonance: a case report. J Med Case Reports. 2012;6(1):22.
Elbayed K, Berl V, Debeuckelaere C, et al. HR-MAS NMR spectroscopy of reconstructed human epidermis: potential for the in situ investigation of the chemical interactions between skin allergens and nucleophilic amino acids. Chem Res Toxicol. 2013;26(1):136-145.
Debeuckelaere C, Berl V, Elbayed K, Moussallieh F-M, Namer I-J, Lepoittevin J-P. Matrix effect of human reconstructed epidermis on the Chemoselectivity of a skin sensitizing α-methylene-γ-Butyrolactone: consequences for the development of in Chemico alternative methods. Chem Res Toxicol. 2015;28(11):2192-2198.
Debeuckelaere C, Moussallieh F-M, Elbayed K, et al. In situ chemical behaviour of methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) in reconstructed human epidermis: a new approach to the cross-reactivity issue. Contact Dermatitis. 2016;74(3):159-167.
Moss E, Debeuckelaere C, Berl V, et al. In situ metabolism of Cinnamyl alcohol in reconstructed human epidermis: new insights into the activation of this fragrance skin sensitizer. Chem Res Toxicol. 2016;29(7):1172-1178.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc, Ser B. 1995;57:289-300.
Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90-95.
Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in python. J Machine Learn Res. 2011;12:2825-2830.
Martínez-Granados B, Monleón D, Martínez-Bisbal MC, et al. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy. NMR Biomed. 2006;19(1):90-100.
Mazurek S, Zwerschke W, Jansen-Dürr P, Eigenbrodt E. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Biochem J. 2001;356(Pt 1):247-256.
van Waarde A, Elsinga PH. Proliferation markers for the differential diagnosis of tumor and inflammation. Curr Pharm Design. 2008;14(31):3326-3339.
Dutkiewicz EP, Hsieh KT, Wang YS, Chiu HY, Urban PL. Hydrogel micropatch and mass spectrometry-assisted screening for psoriasis related skin metabolites. Clin Chem. 2016;62(8):1120-1128.
Sitter B, Johnsson MK, Halgunset J, Bathen TF. Metabolic changes in psoriatic skin under topical corticosteroid treatment. BMC Dermatol. 2013;13:8.
No Comments.